Cancer Network: Survival improvements seen with matched targeted therapy through multigene sequencing in HER2-negative breast cancer

Dr. Virginia Kaklamani, breast oncologist at the Mays Cancer Center for patient care services within the UT Health San Antonio MD Anderson Cancer Center, is quoted in this story.

Read story

Share This Article!